VEG111485: A QTc Study of Pazopanib

Clinical trial NCT00861029 · COMPLETED

Trial details

NCT number: NCT00861029
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2009-03-19
Primary completion: 2010-02-15
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.